Asbestos Diseases Research Institute Biobank

Certification Status: Approved
Registration Status: Completed
Objective:

The ADRI biobank was established to support research into asbestos-related diseases. The biobank contains fresh frozen tumour tissue, DNA and RNA samples derived from tumour tissue and matched bloods from mesothelioma patients, control tissue samples and series of formalin-fixed tumour tissues.

Registered Biobank Name Asbestos Diseases Research Institute Biobank (ADRI Biobank)
Biobank Leader victoria keena
Principal Investigator Professor Ken Takahashi
Address Gate 3 Hospital Road
Concord, NSW, Australia
Website
Email for biobank inquiries Victoria.Keena@sydney.edu.au
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Oligo - Collection aimed at supporting several research projects, a research group or a research consortium
Biospecimen Collected: